Hepatitis B vaccine: From prevention to treatment / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 1021-1025, 2024.
Article
em Zh
| WPRIM
| ID: wpr-1030797
Biblioteca responsável:
WPRO
ABSTRACT
Hepatitis B vaccination is the most economical and effective way to prevent HBV infection. The advances in molecular biology and genetic engineering have continuously improved the manufacturing process of vaccines, and hepatitis B vaccine has gradually developed from the initial plasma-derived vaccine to the currently used recombinant vaccine. Preventive hepatitis B vaccine has been clinically tested in patients with HBsAg seroclearance to increase the level of anti-HBs, with certain safety and efficacy. As one of the multiple targets for new drugs in the treatment of chronic hepatitis B, a therapeutic hepatitis B vaccine based on HBsAg is already in the stages of research and development and clinical trial.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Clinical Hepatology
Ano de publicação:
2024
Tipo de documento:
Article